European Union And Industry Launch Massive Pharmaceutical R&D Program

The European Commission and European drug makers have agreed to spend €2 billion, almost $3 billion, to develop technologies that can speed the development and delivery of new drugs to patients

More from Archive

More from Pink Sheet